Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, November 2004, p. 4444-4446, Vol. 48, No. 11
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.11.4444-4446.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Department of Pediatrics and Adolescent Medicine, University Hospital Freiburg, Freiburg,1 Robert Koch Institute, Berlin, Germany2
Received 8 January 2004/ Returned for modification 25 May 2004/ Accepted 20 July 2004
The antimicrobial susceptibility of 296 invasive neonatal group B streptococcus isolates from a nationwide 2-year surveillance study in Germany was investigated. All isolates were susceptible to beta-lactams, linezolid, quinupristin-dalfopristin, and vancomycin. Erythromycin and clindamycin resistance was found in 10.1 and 5.7%, respectively. The ermB, ermTR, or mefA gene was detected in all but one of the erythromycin-resistant isolates.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»